Wael Alturaiki

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Molecular Docking

Tyrosine Kinase

Respiratory Syndrome Coronavirus

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Saudi medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Wael Alturaiki
Immunomodulatory effects of BAFF and APRIL cytokines in post-pulmonary infection lung cancer: Implications for drug resistance and progression. Saudi medical journal 45 (3) (2024)
Wael Alturaiki
Immunomodulatory effects of BAFF and APRIL cytokines in post-pulmonary infection lung cancer: Implications for drug resistance and progression. Saudi medical journal 45 (3) (2024)
Wael Alturaiki
Immunomodulatory effects of BAFF and APRIL cytokines in post-pulmonary infection lung cancer: Implications for drug resistance and progression. Saudi medical journal 45 (3) (2024)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Maaweya E Awadalla, Haitham Alkadi, Modhi Alarjani, Abdullah E Al-Anazi, Mohanad A Ibrahim, Thamer Ahmad ALOhali, Mushira Enani, Wael Alturaiki, Bandar Alosaimi
Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains. Vaccines 11 (6) (2023)
Maaweya E Awadalla, Haitham Alkadi, Modhi Alarjani, Abdullah E Al-Anazi, Mohanad A Ibrahim, Thamer Ahmad ALOhali, Mushira Enani, Wael Alturaiki, Bandar Alosaimi
Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains. Vaccines 11 (6) (2023)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Sami G Almalki, Yaser E Alqurashi, Wael Alturaiki, Saud Almawash, Amir Khan, Parvej Ahmad, Danish Iqbal
Antioxidant, LC-MS Analysis, and Cholinesterase Inhibitory Potentials of Phoenix dactylifera Cultivar Khudari: An In Vitro Enzyme Kinetics and In Silico Study. Biomolecules 13 (10) (2023)
Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz, Ayoub Al Othaim, Wael Alturaiki, Sami G Almalki, Abdulrahman Algarni, Suliman Abdallah Alsagaby
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation. Molecules (Basel, Switzerland) 28 (8) (2023)
Bandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, Halah Z AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A Alrashed, Ahmed A Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J Alshalani, Wael Alturaiki
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Bandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, Halah Z AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A Alrashed, Ahmed A Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J Alshalani, Wael Alturaiki
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Ayman Mubarak, Saeedah Almutairi, Abulrahman D Al-Dhabbah, Shaha Y Aldabas, Rauf Bhat, Mahfoudh M Alqoufail, Mostafa A Abdel-Maksoud, Taghreed N Almanaa, Mohamed A Farrag, Wael Alturaiki
Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population. Infection and drug resistance 15 (2022)
Bandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, Halah Z AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A Alrashed, Ahmed A Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J Alshalani, Wael Alturaiki
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Huda M Alshanbari, Tahir Mehmood, Waqas Sami, Wael Alturaiki, Mauawia A Hamza, Bandar Alosaimi
Prediction and Classification of COVID-19 Admissions to Intensive Care Units (ICU) Using Weighted Radial Kernel SVM Coupled with Recursive Feature Elimination (RFE). Life (Basel, Switzerland) 12 (7) (2022)
Bandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, Halah Z AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A Alrashed, Ahmed A Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J Alshalani, Wael Alturaiki
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sabera Bijani, Danish Iqbal, Sheefa Mirza, Vicky Jain, Sadaf Jahan, Mohammed Alsaweed, Yahya Madkhali, Suliman Abdallah Alsagaby, Saeed S Banawas, Abdulrahman Algarni, Faris A Alrumaihi, Rakesh M Rawal, Wael Alturaiki, Anamik Shah
Green Synthesis and Anticancer Potential of 1,4-Dihydropyridines-Based Triazole Derivatives: In Silico and In Vitro Study. Life (Basel, Switzerland) 12 (4) (2022)
Noopur Khare, Sanjiv Kumar Maheshwari, Syed Mohd Danish Rizvi, Hind Muteb Albadrani, Suliman Abdallah Alsagaby, Wael Alturaiki, Danish Iqbal, Qamar Zia, Chiara Villa, Saurabh Kumar Jha, Niraj Kumar Jha, Abhimanyu Kumar Jha
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer's Disease. Brain sciences 12 (6) (2022)
Wael Alturaiki
Considerations for Novel COVID-19 Mucosal Vaccine Development. Vaccines 10 (8) (2022)
Bandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, Halah Z AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A Alrashed, Ahmed A Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J Alshalani, Wael Alturaiki
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Danish Iqbal, Syed Mohd Danish Rizvi, Md Tabish Rehman, M Salman Khan, Abdulaziz Bin Dukhyil, Mohamed F AlAjmi, Bader Mohammed Alshehri, Saeed S Banawas, Qamar Zia, Mohammed Alsaweed, Yahya Madkhali, Suliman Abdallah Alsagaby, Wael Alturaiki
Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study. Entropy (Basel, Switzerland) 24 (5) (2022)
Rawabi Aljumaiah, Wael Alturaiki, Bandar Alosaimi
Confusion and Hallucination: A Case Report of an Unusual Presentation of COVID-19. Case reports in psychiatry 2021 (2021)
Mohamed A Farrag, Haitham M Amer, Rauf Bhat, Maaweya E Hamed, Ibrahim M Aziz, Ayman Mubarak, Turki M Dawoud, Sami G Almalki, Fayez Alghofaili, Ahmad K Alnemare, Raid Saleem Al-Baradi, Bandar Alosaimi, Wael Alturaiki
SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis. International journal of environmental research and public health 18 (12) (2021)
Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, Syed Mohd Danish Rizvi, Mohamed F Al Ajmi, Bader Mohammed Alshehri, Saeed S Banawas, M Salman Khan, Wael Alturaiki, Mohammed Alsaweed
High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer's Disease through Multitarget Approach. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Saeed Mohammed Alqahtani, Suliman Abdallah Alsagaby, Shabir Ahmad Mir, Mohammed A Alaidarous, Abdulaziz Bin Dukhyil, Bader Alshehri, Saeed S Banawas, Wael Alturaiki, Naif Khalaf Al Harbi, Taif Anwar Azad, Waleed Al Abdulmonem
Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia. Healthcare (Basel, Switzerland) 9 (8) (2021)
Danish Iqbal, M Salman Khan, Mohd Waiz, Md Tabish Rehman, Mohammed A Alaidarous, Azfar Jamal, Abdulaziz S Alothaim, Mohamed F AlAjmi, Bader Mohammed Alshehri, Saeed S Banawas, Mohammed Alsaweed, Yahya Madkhali, Abdulrahman Algarni, Suliman Abdallah Alsagaby, Wael Alturaiki
Exploring the Binding Pattern of Geraniol with Acetylcholinesterase through In Silico Docking, Molecular Dynamics Simulation, and In Vitro Enzyme Inhibition Kinetics Studies. Cells 10 (12) (2021)
Ayman Mubarak, Wael Alturaiki, Maged Gomaa Hemida
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development. Journal of immunology research 2019 (2019)